INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic Cancer
Conditions: Pancreatic Cancer Non-resectable; Pancreatic Cancer Metastatic Intervention: Drug: INCMGA00012 (PD-1 antibody) Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials